SCHEMBL24601658

SCHEMBL24601658

c1ccc(-c2c(-c3ccccc3)c(-c3ccccc3)c(-c3ccc4c(c3)c3c5c6ccccc6n6c7ccc(-c8c(-c9ccccc9)c(-c9ccccc9)c(-c9ccccc9)c(-c9ccccc9)c8-c8ccccc8)cc7c(c7c8ccccc8n4c73)c56)c(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.36
ESR1 P03372 4/20 0.34
ESR2 Q92731 4/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 6/20 0.33
RCE1 Q9Y256 1/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 3/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
EGFR P00533 1/20 0.32
NPY5R Q15761 1/20 0.32
TSHR P16473 2/20 0.31
GAA P10253 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601656 0.93 KDM4E (0.35) ESR1ESR2KMT2ALMNASMN1; SMN2
SCHEMBL22178510 0.91 TSPO (0.43) TSPOHPGDHSD17B10
SCHEMBL22178499 0.91 TSPO (0.43) TSPOHPGDHSD17B10
SCHEMBL24601547 0.91 TSPO (0.34) TSPOESR1ESR2KMT2ALMNA
SCHEMBL22178509 0.88 TSPO (0.41) TSPOESR1KMT2A
SCHEMBL24601509 0.88 HSD17B10 (0.34) TSPOKMT2ALMNASMN1; SMN2KDM4E
SCHEMBL24601657 0.87 KMT2A (0.33) TSPOKMT2ALMNASMN1; SMN2KDM4E
SCHEMBL24601430 0.87 HSD17B10 (0.36) TSPOKMT2AKDM4EHSD17B10MAPT
SCHEMBL24601649 0.87 HSD17B10 (0.36) TSPOKMT2AKDM4EHSD17B10MAPT
SCHEMBL22178583 0.87 HSD17B10 (0.37) TSPOKMT2AKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 TSPO 3404/4885ESR1 1037/4885ESR2 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.